iBio IBIO
NASDAQ IBIO
$1.47 +0.00 (+0.09%)
As of: Aug 21, 2026 · 11:24 AM EDT

iBio (IBIO) EPS (Basic) (2010 - 2026)

iBio (IBIO) posted quarterly EPS (Basic) of -$0.06 for Q1 2026, up 86.89% year-over-year from -$0.03 in Q1 2025, and up 28.75% quarter-over-quarter from -$0.09 in Q4 2025.

iBio (IBIO) EPS (Basic) (2010 - 2026) Analysis & Trends

iBio (IBIO) has reported EPS (Basic) for 17 consecutive years, with -$0.06 the latest figure, recorded in Q1 2026.

  • In Q1 2026, EPS (Basic) rose 86.89% year-over-year to -$0.06; the TTM figure through Mar 2026 stood at -$0.23 (up 87.35% YoY), while the FY2025 annual figure was -$7.77, down 214.45% from the prior year.
  • EPS (Basic) improved to -$0.06 in Q1 2026 per IBIO's latest filing, from -$0.09 in the prior quarter.
  • Across five years, EPS (Basic) topped out at -$0.06 in Q1 2026 and bottomed at -$46.88 in Q4 2022.
  • Historically, EPS (Basic) has averaged -$8.28 across 5 years, with a median of -$0.56 in 2023.
  • On a YoY basis, EPS (Basic) climbed as much as 99.84% in 2022 and fell as far as 30102.89% in 2022.
  • iBio's EPS (Basic) stood at -$46.88 in 2022, then surged by 95.72% to -$2.01 in 2023, then surged by 76.18% to -$0.48 in 2024, then surged by 81.02% to -$0.09 in 2025, then gained by 28.75% to -$0.06 in 2026.
  • Business Quant data shows IBIO's EPS (Basic) at -$0.06 in Q1 2026, -$0.09 in Q4 2025, and -$0.11 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Vertex Pharmaceuticals 139.84 Bn 131.99 Bn 2.84 Bn 4.34
2 Regeneron Pharmaceuticals 86.48 Bn 78.49 Bn 3.93 Bn 12.62
3 Argenx Se 65.47 Bn 60.29 Bn 1.37 Bn 7.59
4 Moderna 60.15 Bn 55.01 Bn 52.00 Mn -1.96
5 BeOne Medicines 42.22 Bn 37.12 Bn 1.53 Bn 2.12
6 Alnylam Pharmaceuticals 31.67 Bn 28.36 Bn 992.69 Mn 1.23
7 BioNTech SE 28.54 Bn 10.14 Bn 668.28 Mn -0.72
8 Insmed 27.58 Bn 26.42 Bn 358.27 Mn -0.06
9 Royalty Pharma 27.22 Bn 26.38 Bn - 0.18
10 iBio 175.97 Mn 175.97 Mn - -0.06

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.06
Dec 31, 2025 -0.09
Sep 30, 2025 -0.11
Jun 30, 2025 -0.46
Mar 31, 2025 -0.49
Dec 31, 2024 -0.48
Sep 30, 2024 -0.46
Jun 30, 2024 -1.18
Mar 31, 2024 -0.14
Dec 31, 2023 -2.01
Sep 30, 2023 -0.56
Jun 30, 2023 -1.80
Mar 31, 2023 -1.54
Dec 31, 2022 -46.88
Sep 30, 2022 -17.05
Jun 30, 2022 -39.11
Mar 31, 2022 -28.40
Dec 31, 2021 -27.39
Sep 30, 2021 -12.06
Jun 30, 2021 0.13